Markus Raderer Selected Research

Bevacizumab (Avastin)

1/2017	The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna.
8/2005	Response of a nonmalignant pleural effusion to bevacizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Raderer Research Topics

Disease

61	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2023 - 09/2002
47	Neoplasms (Cancer) 01/2024 - 03/2002
44	Lymphoma (Lymphomas) 01/2024 - 09/2002
14	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 01/2009
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2023 - 10/2004
7	Infections 02/2023 - 03/2002
7	Diarrhea 10/2021 - 01/2002
7	Disease Progression 10/2021 - 01/2009
6	B-Cell Lymphoma (Lymphoma, B Cell) 06/2021 - 03/2013
5	Nausea 01/2024 - 01/2002
5	Multiple Myeloma 02/2018 - 01/2004
4	Neutropenia 01/2024 - 01/2002
4	COVID-19 02/2023 - 10/2020
4	Inflammation (Inflammations) 07/2022 - 03/2002
4	Fatigue 10/2021 - 04/2003
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2011
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 08/2003
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2010 - 01/2005
3	Carcinoid Tumor (Carcinoid) 01/2023 - 08/2016
3	Breast Neoplasms (Breast Cancer) 11/2019 - 05/2002
3	Adenocarcinoma 01/2018 - 06/2008
3	Stomatitis 03/2016 - 05/2002
3	Autoimmune Diseases (Autoimmune Disease) 03/2016 - 08/2014
3	Esophageal Neoplasms (Esophageal Cancer) 12/2011 - 07/2007
3	Colorectal Neoplasms (Colorectal Cancer) 04/2003 - 01/2002
3	Vomiting 04/2003 - 01/2002
2	Thrombocytopenia (Thrombopenia) 01/2024 - 04/2003
2	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 10/2016
2	Neuroendocrine Carcinoma 01/2021 - 01/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2020 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 01/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 08/2003
2	Neoplasm Metastasis (Metastasis) 10/2017 - 08/2002
2	Anaplastic Thyroid Carcinoma 10/2016 - 09/2010
2	Heart Diseases (Heart Disease) 12/2015 - 02/2010
2	Familial primary gastric lymphoma 06/2015 - 10/2005

Drug/Important Bio-Agent (IBA)

23	Rituximab (Mabthera)FDA Link 06/2021 - 01/2003
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2006
9	Clarithromycin (Biaxin)FDA LinkGeneric 01/2023 - 12/2011
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2015
7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2024 - 07/2014
7	68Ga-pentixaforIBA 01/2024 - 01/2018
7	Lenalidomide (CC 5013)FDA Link 01/2023 - 03/2013
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2013 - 01/2002
6	Chemokine ReceptorsIBA 01/2024 - 11/2016
6	Everolimus FDA Link 01/2023 - 07/2014
6	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 08/2003
6	Cladribine FDA LinkGeneric 06/2017 - 09/2002
5	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 12/2011
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2019 - 01/2004
4	lanreotide (Somatuline)FDA Link 01/2024 - 12/2005
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2016
4	AntigensIBA 01/2020 - 09/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 01/2006
4	Thalidomide (Thalomid)FDA Link 01/2016 - 01/2004
4	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2012 - 02/2005
4	Docetaxel (Taxotere)FDA Link 09/2010 - 05/2002
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2008 - 05/2002
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2024 - 12/2005
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023 - 11/2005
3	Azithromycin (Zithromax)FDA LinkGeneric 02/2023 - 02/2019
3	AntibodiesIBA 01/2022 - 11/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 11/2018 - 02/2005
3	Vincristine (Oncovin)FDA LinkGeneric 11/2018 - 01/2006
3	Bortezomib (Velcade)FDA Link 11/2018 - 05/2009
3	Cisplatin (Platino)FDA LinkGeneric 11/2008 - 01/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 07/2007 - 01/2002
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 01/2024
2	Capecitabine (Xeloda)FDA Link 01/2024 - 04/2003
2	NF-kappa B (NF-kB)IBA 01/2023 - 10/2020
2	Monoclonal AntibodiesIBA 06/2021 - 01/2021
2	MacrolidesIBA 01/2021 - 02/2019
2	Cytostatic AgentsIBA 11/2020 - 02/2010
2	Immunomodulating AgentsIBA 11/2020 - 01/2016
2	Bendamustine Hydrochloride FDA Link 06/2019 - 02/2014
2	Ondansetron (Zofran)FDA LinkGeneric 01/2019 - 05/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 01/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 09/2012
2	purineIBA 06/2017 - 08/2015
2	Bevacizumab (Avastin)FDA Link 01/2017 - 08/2005
2	NivolumabIBA 01/2017 - 01/2016
2	Chlorambucil (Leukeran)FDA Link 01/2017 - 02/2005
2	ParaproteinsIBA 01/2017 - 11/2004
2	somatostatin receptor 2IBA 11/2016 - 10/2016
2	Tumor Biomarkers (Tumor Markers)IBA 08/2016 - 08/2013
2	Peptides (Polypeptides)IBA 12/2015 - 05/2003
2	Hormones (Hormone)IBA 12/2015 - 07/2014
2	AnthracyclinesIBA 08/2015 - 02/2010

Therapy/Procedure

60	Therapeutics 01/2024 - 01/2002
25	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
6	Precision Medicine 01/2024 - 01/2018
6	Aftercare (After-Treatment) 12/2023 - 09/2005
5	Immunotherapy 11/2020 - 08/2002
5	Radiotherapy 01/2019 - 02/2010
4	Stem Cell Transplantation 01/2017 - 01/2005
2	Drug Tapering 10/2021 - 05/2009
2	Transplantation 11/2018 - 01/2015
2	Hematopoietic Stem Cell Mobilization 01/2017 - 02/2006
2	Salvage Therapy 01/2017 - 01/2016